First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery

Kerling A, Toka O, Rueffer A, Mueller H, Habash S, Weiss C, Dittrich S, Moosmann J (2019)

Publication Type: Journal article

Publication year: 2019

Journal

BMC Pediatrics BioMed Central

Book Volume: 19

Pages Range: 57

Journal Issue: 1

DOI: 10.1186/s12887-019-1418-6

Abstract

Background: Postoperative fluid management in critically ill neonates and infants with capillary leak syndrome (CLS) and extensive volume overload after cardiac surgery on cardiopulmonary bypass is challenging. CLS is often resistant to conventional diuretic therapy, aggravating the course of weaning from invasive ventilation, increasing length of stay on ICU and morbidity and mortality.

Authors with CRIS profile

Anne Kerling Professur für Kinderkardiologie Sven Dittrich Department of Paediatric Cardiology Julia Moosmann Department of Paediatrics and Adolescent Medicine

Involved external institutions

Ruprecht-Karls-Universität Heidelberg DE Germany (DE)

How to cite

APA:

Kerling, A., Toka, O., Rueffer, A., Mueller, H., Habash, S., Weiss, C.,... Moosmann, J. (2019). First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery. BMC Pediatrics, 19(1), 57. https://dx.doi.org/10.1186/s12887-019-1418-6

MLA:

Kerling, Anne, et al. "First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery." BMC Pediatrics 19.1 (2019): 57.

BibTeX: Download